UW Medicine starts Novavax COVID-19 vaccine clinical trial (includes Scott McClelland)
Volunteer enrollment begins for Phase III clinical trial that will determine the efficacy of Novavax vaccine candidate.
UW Medicine investigators are starting volunteer enrollment for an investigational COVID-19 vaccine clinical trial. The Phase III study will examine whether the Novavax vaccine candidate can protect against SARS-CoV-2, the coronavirus responsible for COVID-19.